Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098176400> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2098176400 endingPage "172" @default.
- W2098176400 startingPage "172" @default.
- W2098176400 abstract "(2000) JAMA 283, 1967. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. . Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). . Apr 19; . : . –75 . [OpenUrl][1][CrossRef][2][PubMed][3][Web of Science][4] QUESTION: In high risk hypertensive patients, is doxazosin (an α-adrenergic blocker) or chlorthalidone (a diuretic) more effective in reducing cardiovascular disease (CVD) events? Randomised (allocation concealed*), blinded (clinicians and patients),* controlled trial with median 3.3 year follow up. 625 centres in the US and Canada. 24 335 patients who were ≥55 years of age (mean age 67 y, 53% men, 49% white non-Hispanic), had systolic blood pressure (BP) ≥140 mm Hg or diastolic BP ≥90 mm Hg, took medication for hypertension, and had ≥1 other risk factor for coronary heart disease (CHD). {Exclusion criteria included myocardial infarction (MI), stroke, or angina pectoris in the past 6 months; congestive heart failure (CHF) or ejection fraction <35%; or serum creatinine concentration ≥177 μmol/l.}† 97% of patients were included in the analysis. Patients were allocated … [1]: {openurl}?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.issn%253D0002-9955%26rft.aulast%253DThe%2BALLHAT%2BOfficers%2Band%2BCoordinators%2Bfor%2Bthe%2BALLHA%26rft.auinit1%253D%2B%26rft.volume%253D283%26rft.issue%253D15%26rft.spage%253D1967%26rft.epage%253D1975%26rft.atitle%253DMajor%2BCardiovascular%2BEvents%2Bin%2BHypertensive%2BPatients%2BRandomized%2Bto%2BDoxazosin%2Bvs%2BChlorthalidone%253A%2BThe%2BAntihypertensive%2Band%2BLipid-Lowering%2BTreatment%2Bto%2BPrevent%2BHeart%2BAttack%2BTrial%2B%2528ALLHAT%2529%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.283.15.1967%26rft_id%253Dinfo%253Apmid%252F10789664%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/external-ref?access_num=10.1001/jama.283.15.1967&link_type=DOI [3]: /lookup/external-ref?access_num=10789664&link_type=MED&atom=%2Febmed%2F5%2F6%2F172.atom [4]: /lookup/external-ref?access_num=000086436600031&link_type=ISI" @default.
- W2098176400 created "2016-06-24" @default.
- W2098176400 creator A5002821639 @default.
- W2098176400 creator A5066962036 @default.
- W2098176400 date "2000-11-01" @default.
- W2098176400 modified "2023-09-27" @default.
- W2098176400 title "Doxazosin was associated with more stroke and cardiovascular disease events than chlorthalidone in high risk hypertension" @default.
- W2098176400 cites W1667468471 @default.
- W2098176400 cites W2114605626 @default.
- W2098176400 cites W2414167269 @default.
- W2098176400 cites W2614043550 @default.
- W2098176400 doi "https://doi.org/10.1136/ebm.5.6.172" @default.
- W2098176400 hasPublicationYear "2000" @default.
- W2098176400 type Work @default.
- W2098176400 sameAs 2098176400 @default.
- W2098176400 citedByCount "0" @default.
- W2098176400 crossrefType "journal-article" @default.
- W2098176400 hasAuthorship W2098176400A5002821639 @default.
- W2098176400 hasAuthorship W2098176400A5066962036 @default.
- W2098176400 hasBestOaLocation W20981764001 @default.
- W2098176400 hasConcept C126322002 @default.
- W2098176400 hasConcept C127413603 @default.
- W2098176400 hasConcept C164705383 @default.
- W2098176400 hasConcept C2777590997 @default.
- W2098176400 hasConcept C2778198053 @default.
- W2098176400 hasConcept C2778425758 @default.
- W2098176400 hasConcept C2780427769 @default.
- W2098176400 hasConcept C2780645631 @default.
- W2098176400 hasConcept C500558357 @default.
- W2098176400 hasConcept C71924100 @default.
- W2098176400 hasConcept C78519656 @default.
- W2098176400 hasConcept C84393581 @default.
- W2098176400 hasConceptScore W2098176400C126322002 @default.
- W2098176400 hasConceptScore W2098176400C127413603 @default.
- W2098176400 hasConceptScore W2098176400C164705383 @default.
- W2098176400 hasConceptScore W2098176400C2777590997 @default.
- W2098176400 hasConceptScore W2098176400C2778198053 @default.
- W2098176400 hasConceptScore W2098176400C2778425758 @default.
- W2098176400 hasConceptScore W2098176400C2780427769 @default.
- W2098176400 hasConceptScore W2098176400C2780645631 @default.
- W2098176400 hasConceptScore W2098176400C500558357 @default.
- W2098176400 hasConceptScore W2098176400C71924100 @default.
- W2098176400 hasConceptScore W2098176400C78519656 @default.
- W2098176400 hasConceptScore W2098176400C84393581 @default.
- W2098176400 hasIssue "6" @default.
- W2098176400 hasLocation W20981764001 @default.
- W2098176400 hasLocation W20981764002 @default.
- W2098176400 hasOpenAccess W2098176400 @default.
- W2098176400 hasPrimaryLocation W20981764001 @default.
- W2098176400 hasRelatedWork W109966298 @default.
- W2098176400 hasRelatedWork W1864361583 @default.
- W2098176400 hasRelatedWork W2008851126 @default.
- W2098176400 hasRelatedWork W2049397185 @default.
- W2098176400 hasRelatedWork W2125804349 @default.
- W2098176400 hasRelatedWork W2127666157 @default.
- W2098176400 hasRelatedWork W2145712255 @default.
- W2098176400 hasRelatedWork W2155913505 @default.
- W2098176400 hasRelatedWork W2237746437 @default.
- W2098176400 hasRelatedWork W2399063111 @default.
- W2098176400 hasVolume "5" @default.
- W2098176400 isParatext "false" @default.
- W2098176400 isRetracted "false" @default.
- W2098176400 magId "2098176400" @default.
- W2098176400 workType "article" @default.